Zymeworks Inc. Forecast, price target & analysts
Zymeworks Inc. Target price 2026 - Analyst rating & recommendation
Zymeworks Inc. Classifications & Recommendation
Zymeworks Inc. Price Target
| Target Price | $40.80 |
| Price | $25.26 |
| Potential |
61.52%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Zymeworks Inc. 2027 .
The average Zymeworks Inc. target price is $40.80.
This is
61.52%
register free of charge
$63.00
149.41%
register free of charge
$32.32
27.95%
register free of charge
|
|
| A rating was issued by 18 analysts: 17 Analysts recommend Zymeworks Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zymeworks Inc. stock has an average upside potential 2027 of
61.52%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 105.97 | 317.90 |
| 38.89% | 199.99% | |
| EBITDA Margin | -80.04% | 26.72% |
| 45.05% | 133.38% | |
| Net Margin | -76.56% | 32.17% |
| 52.39% | 142.02% |
14 Analysts have issued a sales forecast Zymeworks Inc. 2026 . The average Zymeworks Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Zymeworks Inc. EBITDA forecast 2026. The average Zymeworks Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Zymeworks Inc. Analysts have issued a net profit forecast 2026. The average Zymeworks Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.08 | 1.42 |
| 33.33% | 231.48% | |
| P/E | 17.78 | |
| EV/Sales | 6.01 |
15 Analysts have issued a Zymeworks Inc. forecast for earnings per share. The average Zymeworks Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current Zymeworks Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Locked
➜
Locked
|
Locked | Sep 29 2026 |
| Wolfe Research |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citigroup:
Locked
➜
Locked
|
Sep 29 2026 |
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Aug 10 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
